(Total Views: 755)
Posted On: 04/27/2020 4:35:05 PM
Post# of 154011
Quote:Agreed.
Today was our Tipping point
The risk profile of this stock just changed dramatically. The 'leap of faith' that the drug worked or would be approved -- is no longer required.
Dr. Patterson's groundbreaking COVID findings, along with the (eventual) 2-week readout, will solidify a future that has already been written. We just need to have the patience for everyone else to read the story.
Moreover, the unbelievable level of confidence expressed today relative to the MOA in cancer and other immuno indications more than hints at the incredible opportunities that await us after COVID is tamed.
Going forward, short attacks are nothing more than a gift that will allow you to increase your position.
(10)
(0)
